Founded
Address
Abingworth Bioventures IV LP
38 Jermyn Street
London
SW1Y 6DN
United Kingdom
Website
Recent investment activity
KANDO id: 28362
Corporate information
Official name
Abingworth Bioventures IV Limited Partnership
Registration country
Company type
Venture capital fundFund terms
Funding rounds
Fund Closing USD 350,000,000
USD 350,000,000 ( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
ATP Private Equity Partners I K/S | |||
|
Pennsylvania State Employees' Retirement System (SERS) | USD 20,000,000 (USD 20,000,000) |
Actual initial investment stage
Series B (1)
Investment activity status
Not investing
Selected investments
Displaying 1 - 19 of 19| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Healthcare Brands Intl Ltd | Committed to translating innovative science into meaningful consumer brands. Sold subsidiary, Antula Healthcare, for SEK 1.8bn in April 2011. | N/A | |||
|
|
Ablynx NV | Other | ||||
|
|
Akubio Ltd | Provider of acoustic detection systems for real time analysis of biomolecular behavior | N/A | |||
|
|
Alexza Pharmaceuticals Inc | N/A | ||||
|
|
Broncus Technologies Inc | Developer of interventional bronchoscopy devices for the treatment of chronic lung diseases. | N/A | |||
|
|
Dynogen Pharmaceuticals Inc | Drug company focused on gastrointestinal and genitourinary disorders. | N/A | |||
|
|
Fovea Pharmaceuticals | N/A | ||||
|
|
Gynesonics | N/A | ||||
|
|
Intelligent Medical Implants | N/A | ||||
|
|
Magellan | N/A | ||||
|
|
Novexel | N/A | ||||
|
|
Portola Pharmaceuticals Inc | N/A | ||||
|
|
Powder Med | N/A | ||||
|
|
Prosensa | N/A | ||||
|
|
Supernus Pharmaceuticals Inc | N/A | ||||
|
|
Synosia Therapeutics | Develops innovative treatments for disorders of the central nervous system | N/A | |||
|
|
Syntaxin Ltd | N/A | ||||
|
Zogenix Inc | A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. | Series B Initial investment | |||
|
|
Zogenix Inc | A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. | N/A |